LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-1.97%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$2.43B
AUM Growth
+$435M
(+22%)
Cap. Flow
+$677M
Cap. Flow
% of AUM
27.9%
Top 10 Holdings %
Top 10 Hldgs %
39.01%
Holding
975
New
377
Increased
84
Reduced
94
Closed
348
Top Buys
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
$145M |
| 2 |
CELG
Celgene Corp
CELG
|
$123M |
| 3 |
Amazon
AMZN
|
$100M |
| 4 |
Adobe
ADBE
|
$99.8M |
| 5 |
Netflix
NFLX
|
$92.8M |
Top Sells
| 1 |
Merck
MRK
|
$93.7M |
| 2 |
Union Pacific
UNP
|
$73.4M |
| 3 |
LyondellBasell Industries
LYB
|
$47.4M |
| 4 |
Elanco Animal Health
ELAN
|
$46.3M |
| 5 |
Boston Scientific
BSX
|
$41.7M |
Sector Composition
| 1 | Technology | 26.42% |
| 2 | Healthcare | 18.01% |
| 3 | Communication Services | 13.28% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Union Pacific
UNP
$132B
| $2.3M | 0.02% |
14,219
-453,324
| -97% | -$73.4M |
|
152
KLA
KLAC
$115B
| $2.26M | 0.02% |
+14,200
| New | +$2.26M |
|
153
Vale
VALE
$43.8B
| $2.26M | 0.02% |
196,602
+16,400
| +9% | +$189K |
|
154
West Pharmaceutical
WST
$17.8B
| $2.24M | 0.02% |
+15,800
| New | +$2.24M |
|
155
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.88B
| $2.19M | 0.02% |
+24,425
| New | +$2.19M |
|
156
Marriott International Class A Common Stock
MAR
$73B
| $2.16M | 0.02% |
+17,351
| New | +$2.16M |
|
157
Camden Property Trust
CPT
$11.8B
| $2.14M | 0.02% |
+19,300
| New | +$2.14M |
|
158
VF Corp
VFC
$5.85B
| $2.1M | 0.02% |
+23,646
| New | +$2.1M |
|
159
Intuit
INTU
$186B
| $2.09M | 0.02% |
7,868
+7,468
| +1,867% | +$1.99M |
|
|
QVCGA
160
QVC Group, Inc. Series A Common Stock
QVCGA
$79.4M
| $2.04M | 0.02% |
+4,081
| New | +$2.04M |
|
|
FBM
161
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $2.02M | 0.02% |
+130,399
| New | +$2.02M |
|
|
GBT
162
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.01M | 0.01% |
+41,391
| New | +$2.01M |
|
163
Aflac
AFL
$58.1B
| $1.96M | 0.01% |
+37,377
| New | +$1.96M |
|
164
Toronto Dominion Bank
TD
$128B
| $1.93M | 0.01% |
+33,200
| New | +$1.93M |
|
165
Quest Diagnostics
DGX
$20.1B
| $1.92M | 0.01% |
+17,977
| New | +$1.92M |
|
166
T-Mobile US
TMUS
$284B
| $1.91M | 0.01% |
24,301
-24,110
| -50% | -$1.9M |
|
167
Insulet
PODD
$24.4B
| $1.91M | 0.01% |
+11,600
| New | +$1.91M |
|
|
LTHM
168
DELISTED
Livent Corporation
LTHM
| $1.91M | 0.01% |
284,962
+46,700
| +20% | +$312K |
|
169
Graphic Packaging
GPK
$6.19B
| $1.89M | 0.01% |
+128,184
| New | +$1.89M |
|
170
Dynatrace
DT
$15B
| $1.87M | 0.01% |
+100,000
| New | +$1.87M |
|
171
Ingredion
INGR
$8.21B
| $1.86M | 0.01% |
+22,800
| New | +$1.86M |
|
172
Ryanair
RYAAY
$32B
| $1.86M | 0.01% |
70,000
+3,832
| +6% | +$102K |
|
|
MLNX
173
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.85M | 0.01% |
+16,900
| New | +$1.85M |
|
174
Teva Pharmaceuticals
TEVA
$21.2B
| $1.85M | 0.01% |
269,100
+162,300
| +152% | +$1.12M |
|
|
TWNK
175
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $1.85M | 0.01% |
+132,145
| New | +$1.85M |
|